Prolonged fibroblast growth factor 19 response in patients with primary sclerosing cholangitis after an oral chenodeoxycholic acid challenge

Serge J. Zweers, Elisabeth M. de Vries, Martin Lenicek, Dagmar Tolenaars, D. Rudi de Waart, Kiran V. K. Koelfat, Albert K. Groen, Steven W. M. Olde Damink, Ulrich Beuers, Cyriel Ponsioen, Peter L. M. Jansen, Frank G. Schaap*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)132-140
Number of pages9
JournalHepatology International
Volume11
Issue number1
DOIs
Publication statusPublished - Jan 2017

Keywords

  • Primary sclerosing cholangitis
  • Chenodeoxycholic acid
  • Fibroblast growth factor 19
  • Farnesoid X receptor
  • PRIMARY BILIARY-CIRRHOSIS
  • FARNESOID-X-RECEPTOR
  • HEPATOCELLULAR-CARCINOMA
  • BILE
  • EXPRESSION
  • DISEASE
  • LIVER
  • FIBROBLAST-GROWTH-FACTOR-19
  • MODEL
  • MICE

Cite this